Ozanimod Clinical Trials
6 recruitingDrug
Phase 32Phase 41Phase 21
Showing 1–6 of 6 trials
Recruiting
Phase 3
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
Multiple Sclerosis, Relapsing-Remitting
Bristol-Myers Squibb194 enrolled33 locationsNCT06408259
Recruiting
Effectiveness of Ozanimod in Patients With Steroid-Dependent Ulcerative Colitis
Ulcerative Colitis (UC)
Bristol-Myers Squibb150 enrolled17 locationsNCT07271069
Recruiting
Phase 2Phase 3
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Bristol-Myers Squibb120 enrolled90 locationsNCT05076175
Recruiting
A Study to Learn More About The Safety of Diroximel Fumarate (VUMERITY®) in Participants Who Took it During Pregnancy And About the Health of Their Babies
Multiple Sclerosis
Biogen1,178 enrolled1 locationNCT05688436
Recruiting
Phase 4
Prospective Evaluation of Sequencing From antiCD-20 Therapies to Ozanimod
Relapsing Multiple Sclerosis
University of Colorado, Denver100 enrolled3 locationsNCT06529406
Recruiting
A Post-Marketing Surveillance Study to Assess Safety of Ozanimod in Patients With Moderate to Severe Active UC in Korea
Ulcerative Colitis
Bristol-Myers Squibb3,000 enrolled1 locationNCT06073873